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A B S T R A C T
Objective: A history of foetal death is a risk factor for complications and foetal death in subsequent
pregnancies as most previous risk factors remain present and an underlying cause of death may recur.
The purpose of this study was to evaluate subsequent pregnancy outcome after foetal death and to
compare cases of recurrent foetal death.
Study design: A retrospective cohort study in a tertiary referral centre. All women with a stillbirth
beyond 16 weeks of gestation between January 1999 and December 2004 (n = 193) were identiﬁed. After
providing informed consent, the medical records of 163 women were reviewed until August 2006 in
terms of clinical, medical, obstetric and paediatric data of the pregnancy after the index pregnancy that
resulted in foetal death. The cause of death for reported cases of foetal death and recurrent foetal death
were classiﬁed by a multidisciplinary team according to the Tulip classiﬁcation.
Results: Recurrent foetal death occurred in 11 cases, and various causes were identiﬁed. The cause of
death was explained in seven cases. An association was found between the index foetal death and
subsequent foetal death in some cases, especially in early gestation.
Conclusions: This study illustrates the importance of classifying the cause of recurrent foetal death and
contributing risk factors using the same classiﬁcation system. This provides more insight into the
pathophysiological pathways leading to foetal death, and enables meaningful comparisons to be made in
recurrent foetal death. This is required before preventive strategies can be instituted and implemented to
reduce the risk of foetal death.
 2012 Elsevier Ireland Ltd. All rights reserved.
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Determination of risk factors and the cause of foetal death
contributes to counselling and the management of future
pregnancies, although the possibilities for intervention are limited,
predominantly consisting of increased maternal and foetal
surveillance, extra diagnostic tests and induction of labour near
or at term. Due to underlying causes and pre-existing risk factors, a
history of foetal death is a risk factor for complications and foetal
death in subsequent pregnancies [1–9]. Studies have reported
increased risk of recurrence ranging from 0 to 20-fold [1,10–14].
This risk depends on various characteristics of the index foetal
death, including aetiology. The cause of death is often not
described clearly in studies on recurrent foetal death, in either
the index pregnancy or the subsequent pregnancy with an adverse
outcome. As such, tailored management based on cause-speciﬁc* Corresponding author at: Department of Obstetrics and Gynaecology,
University Medical Centre Groningen, CB 21, P.O. Box 30001, 9700 RB Groningen,
The Netherlands. Tel.: +31 50 3613020; fax: +31 50 3611806.
E-mail address: j.w.nijkamp@umcg.nl (J.W. Nijkamp).
0301-2115/$ – see front matter  2012 Elsevier Ireland Ltd. All rights reserved.
http://dx.doi.org/10.1016/j.ejogrb.2012.10.008recurrence of foetal death is often not possible. The purpose of this
study was to evaluate pregnancy outcome after foetal death with a
known cause classiﬁed according to the Tulip classiﬁcation [15],
and to describe the relationship with the cause of death in the case
of recurrent foetal death.
2. Materials and methods
At the authors’ tertiary centre, all cases of foetal death beyond
16 weeks of gestation are registered in a validated perinatal
database. A case record form is completed that includes baseline
characteristics such as date of delivery, gestational age, medical
and obstetric history, maternal characteristics, foetal character-
istics including foetal weight at birth, pregnancy details, and
diagnostic test results including pathological ﬁndings from
autopsy and placental investigation. Cause of death and risk
factors involved in cases of foetal death are classiﬁed by a
multidisciplinary team according to the Tulip classiﬁcation; a
system used to determine the cause and mechanism of perinatal
death. This system consists of six main causes of death: congenital
anomaly, placenta (placental bed pathology, placental pathology,
umbilical cord complications), prematurity/immaturity [preterm
J.W. Nijkamp et al. / European Journal of Obstetrics & Gynecology and Reproductive Biology 166 (2013) 37–4238prelabour rupture of membranes (PPROM), preterm labour],
infection, other (foetal hydrops, maternal diseases, trauma, out
of the ordinary) and unknown (despite thorough investigation,
important information missing). Only one cause of death is
allocated. Risk factors are deﬁned as other known contributing
factors on the causal pathway to death [15].
For this retrospective cohort study, women with a foetal death
beyond 16 weeks of gestation between January 1999 and
December 2004 were identiﬁed from the perinatal database. The
cases identiﬁed are termed the ‘index pregnancies’. All women
lived in the north of the Netherlands and had full access to medical
care. In 2005, the study group returned a self-completed
questionnaire about their obstetric history after their index
pregnancy. In addition, medical records were reviewed until
August 2006 to collect clinical obstetric and paediatric data for the
ﬁrst pregnancy after the index pregnancy. Information acquired
from medical records included medical history after the previous
stillbirth, lifestyle characteristics, prenatal care, delivery and infant
outcomes. Obstetric and medical history of the mother included
age (at the beginning of the pregnancy), parity and current
maternal diseases. Intra-uterine growth restriction (IUGR) wasTable 1
Cause of death in the index pregnancy classiﬁed according to the Tulip classiﬁcation (
Cause of death n (% of total) Subclassiﬁcat
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Pregnancy outcome after the index pregnancy (n = 163) by cause of death in the index
Cause of death in 
Total Congenital
anomaly
n % n % 
Obstetric outcome
Total (n = number of women) 163 100.0 24 100.0 
No pregnancy 28 17.2 3 12.5 
Miscarriage before 16 weeks 16 9.8 2 8.3 
Ongoing single pregnancy after 16 weeks 113 69.3 17 70.8 
Ongoing twin pregnancy after 16 weeks 6 3.7 2 8.3 
Outcome ongoing pregnancies after index
Total (n = number of children) 125 100.0 21 100.0 
Foetal death between 17 and 22 weeks 7 5.6 0 0.0 
Foetal death after 22 weeks 5 4.0 0 0.0 
Neonatal death (before 28 days of age) 0 0 0 0.0 
Living child (at 28 days) 113 90.4 21 100.0 deﬁned as birth weight below the 10th percentile of the
Amsterdam birthweight chart [16]. Body mass index (BMI) greater
than or equal to 30 kg/m2 was deﬁned as obesity.
Pregnancy outcomes after the index pregnancy were catego-
rized as miscarriage before 16 weeks of gestation, foetal death
between 16 and 22 weeks of gestation, foetal death beyond 22
weeks of gestation, neonatal death and a living child 28 days after
birth. Neonatal death was deﬁned as the death of a live-born child
before 28 days of age. Abstaining from pregnancy was also
registered. For all cases, gestational age at delivery was based on
early ultrasound and the last menstrual period. Cause of foetal
death in subsequent pregnancies was classiﬁed similarly to index
pregnancies.
Data were analyzed using Statistical Package for the Social
Sciences Version 14.0 (SPSS Inc., Chicago, IL, USA). Continuous
variables are expressed as means, and categorical variables are
expressed as frequencies and percentages. Ninety-ﬁve percent
conﬁdence intervals were computed if appropriate. The study was
approved by the Medical Ethics Committee of the University
Medical Centre Groningen, and all women gave informed consent.n = 163).
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n % n % n % n % n %
79 100.0 14 100.0 4 100.0 7 100.0 35 100.0
13 16.5 2 14.3 2 50.0 0 0 8 22.9
8 10.1 1 7.1 0 0.0 2 28.6 3 8.5
54 68.3 11 78.6 2 50.0 5 71.4 24 68.6
4 5.1 0 0.0 0 0.0 0 0.0 0 0.0
62 100.0 11 100.0 2 100.0 5 100.0 24 100.0
2 3.2 2 18.2 0 0.0 0 0.0 3 12.5
3 4.9 1 9.1 0 0.0 0 0.0 1 4.2
0 0 0 0 0 0.0 0 0.0 0 0.0
57 91.9 8 72.7 2 100.0 5 100.0 20 83.3
Table 3
Recurrent foetal death after explained cause of death in the index pregnancy classiﬁed according to the Tulip classiﬁcation.
Index pregnancy Subsequent pregnancy
Case 1
Mother: 27 years of age, G8P3-1A4, 28 weeks of gestation, girl, 912g, died in utero Mother: 30 years of age, G9P3-2A4, 33 weeks of gestation, boy, 1790g, died in utero
Cause of death Placenta; placental bed pathology: placental abruption Cause of death Placenta; placental bed pathology: placental abruption
Contributing factors Smoking (10 cigarettes/day), congenital anomaly (neural tube defect) Contributing factor Smoking (10 cigarettes/day)
Comorbidities Asthma, protein C deﬁciency, heterozygous factor V Leiden mutation Comorbidities Asthma, protein c deﬁciency, heterozygous factor
V Leiden mutation
Case 2
Mother: 20 years of age, G3P0A2, 28 weeks of gestation, boy, 550g, died in utero Mother: 21 years of age, G4P1-1A2, 21 weeks of gestation, boy, 130g, died in utero
Cause of death Placenta; placental pathology; parenchyma: massive perivillous ﬁbrin
deposition
Cause of death Placenta; placental pathology; parenchyma: massive
perivillous ﬁbrin deposition
Contributing factors Scleroderma, IUGR, oligohydramnion Contributing factors Scleroderma, IUGR
Comorbidities Mitral stenosis and mitral insufﬁciency Comorbidities Mitral stenosis and mitral insufﬁciency
Case 3
Mother: 22 years of age, G3P1A1, biamniotic bichorionic twin pregnancy, 23 weeks of gestation, girl
400g, boy 435g, both died during labour
Mother: 23 years of age, G4P2-1A1, 20 weeks of gestation, girl, 220g
Cause of death Prematurity; PPROM since 19 weeks of gestation Cause of death Prematurity; PPROM since 20 weeks of gestation
Contributing factors CIN III lesion treated with LETZ, twin pregnancy, chorioamnionitis,
smoking (10 cigarettes/day)
Contributing factors CIN III lesion treated with LETZ, smoking (5 cigarettes/day)
Comorbidities Congenital heart disease with Mustard correction Comorbidities Congenital heart disease with Mustard correction
Case 4
Mother: 34 years of age, G1P0, 17 weeks of gestation, girl, 310g, died in utero Mother: 36 years of age, G2P1-1, 21 weeks of gestation, girl, 330g, died in utero
Cause of death Prematurity; PPROM since 17 weeks of gestation Cause of death Prematurity; PPROM since 20 weeks of gestation
Contributing factor Chorioamnionitis Contributing factors Chorioamnionitis, umbilical cord prolapse
Comorbidities Leiomyoma, endometriosis Comorbidities Leiomyoma, endometriosis
Case 5
Mother: 32 years of age, G2P1,monoamnioticmonochorionic twin pregnancy, TRAP sequence requiring laser
therapy. Foetus I: acardiac foetus died during laser therapy; foetus II: 25 weeks of gestation, boy, 745g, died
in utero (3 weeks after laser therapy)
Mother: 34 years of age, G3P2-1, monoamniotic monochorionic twin pregnancy, foetus 1: boy,
135g, died in utero at 17weeks of gestation; foetus II: boy, 970g, died in utero at 30weeks of gestation
Cause of death Placenta; placental pathology; development Cause of death foetus I
Cause of death foetus II
Unknown, despite thorough investigation
Placenta; placental pathology, development
Contributing factors Monoamniotic monochorionic twin pregnancy, TRAP sequence, IUGR Contributing factors Monoamniotic monochorionic twin, IUGR, oligohydramnion
Comorbidities None Comorbidities None
Case 6
Mother: 24 years of age, G2P1, 27 weeks of gestation, girl, 780g, died in utero Mother: 25 years of age, G3P2-1, 30 weeks of gestation, girl, 1010g, died in utero
Cause of death Prematurity; preterm labour Cause of death Placenta; placental bed pathology
Contributing factor Cardiocirculatory insufﬁciency due to niﬁdipine-induced hypotension Contributing factors None
Comorbidities None Comorbidities None
Case 7
Mother: 24 years of age, G1P0, 24 weeks of gestation, girl, 685g, died in utero Mother: 26 years of age, G2P1-1, 20 weeks of gestation, boy, 340g, died during labour
Cause of death Placenta; placenta bed pathology Cause of death Prematurity; preterm labour
Contributing factors HELLP syndrome, pre-eclampsia, obesity (BMI 39) Contributing factor Obesity (BMI 40)
Comorbidities Heterozygous factor V Leiden mutation Comorbidities Heterozygous factor V Leiden mutation





































































Recurrent foetal death after unexplained cause of death in the index pregnancy classiﬁed according to the Tulip classiﬁcation.
Index pregnancy Subsequent pregnancy
Case 8
Mother: 37 years of age, G5P4, 18 weeks of gestation, boy, 50 g, died
in utero
Mother: 38 years of age, G6P5-1, 21 weeks of gestation, girl, 135 g, died in utero
Cause of death Unknown; despite thorough investigation Cause of death Unknown; despite thorough investigation
Contributing factor Age of mother Contributing factor Age of mother
Comorbidities None Comorbidities None
Case 9
Mother: 33 years of age, G5P4, 27 weeks of gestation, girl, 155 g, died
in utero
Mother: 33 years of age, G6P5-1, 18 weeks of gestation, boy, 50 g, died in utero
Cause of death Unknown; despite thorough investigation Cause of death Unknown; despite thorough investigation
Contributing factor Obesity (BMI 30) Contributing factor Obesity (BMI 30)
Comorbidities None Comorbidities None
Case 10
Mother: 40 years of age, G3P1A1, 19 weeks of gestation, girl, 45 g,
died in utero
Mother: 41 years of age, G4P2-1A1, 23 weeks of gestation, girl, 460 g, died during labour
Cause of death Unknown; despite thorough investigation Cause of death Congenital anomaly; chromosomal defect; numerical (trisomy 18)
Contributing factor Age of mother Contributing factor Age of mother
Comorbidity Leiomyoma Comorbidity Leiomyoma
Case 11
Mother: 40 years of age, G6P5-2, 20 weeks of gestation, boy, 240 g,
died in utero
Mother: 41 years of age, G7P5-3, 29 weeks of gestation, boy, 1500 g, died in utero
Cause of death Unknown; important information missing Cause of death Placenta; placental bed pathology: placental abruption
Contributing factors Age of mother, hyperhomocysteinaemia Contributing factors Age of mother, hyperhomocysteinaemia
Comorbidities None Comorbidities None
BMI: body mass index.
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The authors identiﬁed 193 women with a foetal death beyond
16 weeks of gestation in the perinatal database. Thirty women who
could not be traced due to a change in address or who did not give
permission for use of their medical records after the index
pregnancy were excluded. The excluded women were comparable
to the study group in terms of age, parity and cause of death in the
index pregnancy. Medical records for 163 women were reviewed.
Table 1 shows the cause of death in the index pregnancy classiﬁed
by the Tulip classiﬁcation. Contributing factors and comorbidities
were known for all index pregnancies.
Table 2 shows the pregnancy outcome after the index
pregnancy, categorized by cause of death in the index pregnancy.
Out of 163 women, 119 women (73.0%) had a subsequent ongoing
pregnancy beyond 16 weeks of gestation, including six twin
pregnancies (5.0%). For 16 women (9.8%), the subsequent
pregnancy resulted in a miscarriage before 16 weeks of pregnancy.
Twenty-eight women (17.2%) abstained from pregnancy.
Six of the subsequent pregnancies ended in foetal death
between 17 and 22 weeks of gestation, and ﬁve of the subsequent
pregnancies resulted in foetal death beyond 22 weeks of gestation.
In one twin pregnancy, one foetal death occurred in early gestation
and one foetal death occurred beyond 22 weeks of gestation. These
11 pregnancies (including one twin pregnancy) were also classiﬁed
according to the Tulip classiﬁcation including cause of death,
contributing risk factors and comorbidities.
The cause of death in the index pregnancy was explained in
seven cases. Table 3 shows the cause of death in these seven cases
in comparison with the cause of death in the subsequent
pregnancy. Table 4 shows the results for both the index pregnancy
and the subsequent pregnancy for the four cases where the cause
of death in the index pregnancy was unexplained. Contributing
factors are described.
4. Comment
There is no international consensus regarding which system
should be used for classiﬁcation of perinatal mortality. Since 1954,more than 30 classiﬁcation systems for perinatal mortality have
been introduced [17]. The Tulip classiﬁcation was used in this
study; this system was designed using a pathophysiological
background to identify the unique initial demonstrable entity on
the causal pathway to death for the purposes of counselling and
prevention [15]. The proportion of unexplained stillbirths depends
on which classiﬁcation system is used, varying from 9.5% up to
50.2%. In comparison with other classiﬁcation systems, the Tulip
classiﬁcation has been shown to have the best inter-rater
agreement and a low proportion of unexplained stillbirths [17].
Risk factors are described as contributing factors. In the literature,
known risk factors for perinatal mortality are maternal comorbid-
ities (hypertension, diabetes), advanced maternal age, smoking,
obesity and multiple gestation [14,18–23]. The use of different
classiﬁcation systems for foetal death limits the possibility for
meaningful comparisons between countries regarding causes of
foetal death.
Due to underlying risk factors and causes, a history of foetal
death poses a risk for adverse pregnancy outcome in subsequent
pregnancies with an increased rate of complications and foetal
death. Black et al. performed a retrospective study including 364
women, and found no increased incidence of stillbirth (after 20
weeks of gestation) compared with a control group following
adjustment for pre-eclampsia, abruption, preterm delivery and
low birth weight [10]. In this study, 44% of all stillbirths were
unexplained. Lurie et al. reported a favourable pregnancy outcome
following stillbirth in a cohort of 54 women [11]. In contrast,
Sharma et al. suggested that a history of foetal death beyond 20
weeks of gestation was associated with an almost six times higher
risk of recurrence (hazard ratio 5.8, 95% conﬁdence interval 3.7–
9.0) [13]. However, the cause of death in subsequent pregnancies
was often not described clearly in these studies, and the risk of
recurrent foetal death was estimated for all causes of death
together. For the purposes of counselling and prevention,
determination of the cause of death and risk factors for a previous
foetal death is essential. No previous studies have described
recurrent foetal death using a comparison of the cause of death in
the index pregnancy and the cause of death in the subsequent
pregnancy, both classiﬁed using a validated classiﬁcation system.
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foetal death according to the Tulip classiﬁcation. In the authors’
tertiary referral centre, foetal deaths between 16 and 22 weeks of
gestation are registered and the cause of death is classiﬁed in the
same way as late stillbirths; this differs from other registration
systems. The most common cause of death in the index
pregnancies in this study was placental (78/163, 47.8%). The
variations in cause of death in the index pregnancy (Table 1) were
comparable to the ﬁndings of other studies using the Tulip
classiﬁcation, which also found that a placental cause of death was
most common [25,26].
Out of 163 women, 28 women (17.2%) did not become pregnant
again after their index pregnancy (Table 2). Unfortunately, it is not
known whether this was due to general anxiety, no desire to
become pregnant again or problems with conception.
Out of 11 cases of recurrent foetal death, the causes of death
were explained for the index pregnancy and the subsequent
pregnancy in seven cases (Table 3). Cause-speciﬁc recurrence of
foetal death was caused by placental pathology and prematurity
(Cases 1–4). In Case 1, the cause of death in both pregnancies was
ascribed to placental abruption without signs of massive infarc-
tion, known to have a recurrence risk of 9–15% [1,24]. A
contributing risk factor was smoking. Placental pathology origi-
nated during development of the placenta itself, abnormalities in
the parenchyma or localization of the placenta. Case 2 was an
example of an acquired placenta parenchyma disorder of the villi
and intervillous space. The cause of recurrent foetal death in Case 2
was massive perivillous ﬁbrin deposition (MPFD) in a woman with
systemic sclerosis. Recurrent adverse pregnancy outcome in
systemic sclerosis is well known, and miscarriages, foetal death
and premature births are common, partly due to placental
pathology, including MPFD [27]. After a pregnancy that was
complicated by PPROM, the risk of recurrence is increased 20-fold
and the risk of recurrent preterm delivery is increased almost four-
fold [28]. In two cases (Cases 3 and 4), the cause of death was
explained by recurrent PPROM which initiated preterm delivery.
Pathological placental examination showed signs of chorioamnio-
nitis, intervillositis and deciduitis. There were no clinical signs of
intra-uterine infection. Contributing risk factors in Case 3 were a
twin pregnancy (index pregnancy) and history of a loop electro-
section of the transformation zone because of a cervical intra-
epithelial neoplasia III lesion. In Case 5, the index pregnancy and
the subsequent pregnancy were spontaneous monoamniotic
monochorionic twin pregnancies ending in two stillbirths; the
cause of death was non-optimal placental development. Contrib-
uting factors were twin pregnancy and intra-uterine foetal growth
restriction. The risk of foetal death in monoamniotic twin
pregnancy in the Dutch population is 19% [29]. It is very rare to
have a spontaneous monoamniotic pregnancy twice. In Cases 6 and
7, the cause of death differed between the index pregnancy and the
subsequent pregnancy: preterm labour vs. placental bed patholo-
gy. Placental bed pathology is known to be associated with preterm
delivery [30], but this could not be conﬁrmed on placental
examination in Case 6 and death in both pregnancies was classiﬁed
differently. In Case 7, the placenta of the index pregnancy was not
submitted for examination.
In three cases, the cause of death in the index pregnancy was
unexplained despite thorough investigation; placental examina-
tion and autopsy were performed (Table 4). In Cases 8 and 9, the
cause of the subsequent foetal death was also unknown. The
only known contributing risk factors were the age of the mother
and obesity. In Case 10, there was no clear relationship between
the causes of death in the two pregnancies; cytogenetic analyses
in the index pregnancy showed a normal karoytype. In Case 11,
the cause of death in the index pregnancy was unexplained
because important information was missing; neither placentalexamination nor autopsy were not performed. As the cause of
the subsequent foetal death was placental bed pathology, the
lack of examination of the placenta in the index pregnancy was a
missed opportunity for the parents to have more speciﬁc
counselling.
The results show an association between the cause of death in
the index pregnancy and the cause of death in the subsequent
pregnancy in half of the cases, especially in early gestation. This
illustrates the importance of registration and classiﬁcation of foetal
losses at early gestation, which is often underestimated in
reporting systems [2]. Unfortunately, due to the small population
size, the risk of recurrent foetal death with the same cause as the
index pregnancy could not be established.
In summary, this study shows various causes of foetal death.
There seems to be a relationship between the cause of death in the
index pregnancy and the cause of death in the subsequent
pregnancy, especially in early gestation. It is important to identify
the cause of death to enable the parents to receive more
appropriate counselling about risk in a subsequent pregnancy,
and to institute preventive strategies to reduce the risk of foetal
death. Before preventive strategies can be instituted and imple-
mented to reduce the risk of foetal death, the causes and
mechanisms of antepartum death, risk factors related to the cause
of death and the risk of recurrence need to be well deﬁned. Obligate
investigations include autopsy and placental examination.
This study illustrates that using a validated classiﬁcation
system for recurrent foetal death, where both deaths were
classiﬁed in the same way, provides more insight into pathophysi-
ological pathways leading to foetal death. This will aid under-
standing of foetal death and enable meaningful comparisons to be
made in cases of recurrent foetal death. Identiﬁcation and
registration of the cause of death in early gestation is essential
for further research. In this way, more research can be performed
studying the origin of these causes and may provide more
preventive strategies.
A limitation of this study is that the study population was small.
A large population-based study is necessary to conﬁrm cause-
related recurrent foetal death and to establish the risk of
recurrence.
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